http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104177632-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-09
filingDate 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104177632-B
titleOfInvention A kind of by the core crosslinking micelle prepared containing two pentacyclic cross-linking agent of ortho esters and synthetic method thereof and application
abstract The invention discloses a kind of core prepared by two pentacyclic cross-linking agent of ortho esters crosslinking micelle and synthetic method thereof and application, belong to polymer support and slow controlled-release material technical field.The structure of the described core crosslinking micelle prepared by two pentacyclic cross-linking agent of ortho esters is as shown in chemistry formula I.Utilizing amphipathic nature block polymer PEG-b-PNSM to be self-assembly of micelle in aqueous, the crosslinking micelle adding cross-linking agent formation can carry the medicine (such as antitumor paclitaxel) being insoluble in water in vivo.The core crosslinking micelle of the present invention has good sensitivity to acid, biocompatibility and biodegradability, has a good application prospect in targeted therapy field. In formula, X represents numerical value 20-200.
priorityDate 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103588752-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457569339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449533975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423512670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407932856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53436406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343

Total number of triples: 44.